The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune landscape of breast tumors with low and intermediate estrogen receptor (ER) expression.
 
Leonie Voorwerk
No Relationships to Disclose
 
Hugo M. Horlings
No Relationships to Disclose
 
Joyce Sanders
No Relationships to Disclose
 
Milou S. Keusters
No Relationships to Disclose
 
Sten Cornelissen
No Relationships to Disclose
 
Gabe S. Sonke
Consulting or Advisory Role - Biovica (Inst); Novartis (Inst); Seagen (Inst)
Research Funding - Agendia (Inst); AstraZeneca/Merck (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
 
Sabine C. Linn
Consulting or Advisory Role - Daiichi Sankyo (Inst)
Research Funding - Agendia (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eurocept Pharmaceuticals (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH (Inst)
 
Marleen Kok
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo (Inst); Bristol-Myers Squibb/Medarex (Inst); MSD (Inst); Roche (Inst)
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Roche (Inst)